MediPharm Labs Inc specializes in extraction and is the first company to get an oil production license without a cultivation license in Canada. CEO Pat McCutcheon explains that MediPharm has the largest extraction footprint in the country and will be doubling its production capacity to over 200,000 kilos by the end of Q1 next year. MediPharm creates pharmaceutical-grade CBD extracts for medical and recreational end product production. MediPharm is going public in mid-September, at just over $82 million. McCutcheon believes there’s great investor value in MediPharm, compared to competitors Neptune (NASDAQ:NEPT) (TSE:NEPT) and Radient (CVE:RTI) (OTCMKTS:RDDTF) (FRA:RD8), because of the company’s existing inventory, customer, base, and plan to generate wholesale and processing revenue.

************************

Check out our website:
https://midasletter.com

************************

SUBSCRIBE to our YouTube:
http://bit.ly/MidasLetterYoutube

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter:
http://bit.ly/MidasLetterTwitter

Like Us on Instagram:
http://bit.ly/MidasLetterInsta

Like Us on Facebook:
http://bit.ly/MidasLetterFacebook

************************

#MediPharm
#Cannabis
#WeedStocks